{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:08:01Z","timestamp":1794632881242,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL-125128"],"award-info":[{"award-number":["R01 HL-125128"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-133351 to Y.P.D."],"award-info":[{"award-number":["AI-133351 to Y.P.D."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005640","name":"Flight Attendant Medical Research Institute","doi-asserted-by":"publisher","award":["CIA-123062 to Y.P.D."],"award-info":[{"award-number":["CIA-123062 to Y.P.D."]}],"id":[{"id":"10.13039\/100005640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijantimicag.2018.04.019","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:56:15Z","timestamp":1525928175000},"page":"667-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7017-8483","authenticated-orcid":false,"given":"Qiao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthony","family":"Deslouches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Montelaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Peter","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0001","doi-asserted-by":"crossref","first-page":"e67950","DOI":"10.1371\/journal.pone.0067950","article-title":"Purification and characterization of biofilm-associated EPS exopolysaccharides from ESKAPE organisms and other pathogens","volume":"8","author":"Bales","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0002","doi-asserted-by":"crossref","unstructured":"Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl 2013:1-51.","DOI":"10.1111\/apm.12099"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0003","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0014-5793(97)00189-0","article-title":"Cystic fibrosis, lung infections, and a human tracheal antimicrobial peptide (hTAP)","volume":"405","author":"Ko","year":"1997","journal-title":"FEBS letters"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0004","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/AAC.49.8.3208-3216.2005","article-title":"Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications","volume":"49","author":"Deslouches","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0005","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.03937-14","article-title":"Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens","volume":"59","author":"Deslouches","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0006","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/jac\/dkw143","article-title":"Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells","volume":"71","author":"Lashua","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ijantimicag.2018.04.019_bib0007","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmi.2017.08.029","article-title":"Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.49.1.316-322.2005","article-title":"De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity","volume":"49","author":"Deslouches","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0010","article-title":"Microtiter dish biofilm formation assay","volume":"47","author":"O'Toole","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0011","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.4049\/jimmunol.1202340","article-title":"Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice","volume":"191","author":"Liu","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2958.1998.01062.x","article-title":"Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development","volume":"30","author":"O'Toole","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0013","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2958.2009.06654.x","article-title":"Control of Pseudomonas aeruginosa AlgW protease cleavage of MucA by peptide signals and MucB","volume":"72","author":"Cezairliyan","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10254-004-0031-7","article-title":"Pseudomonas aeruginosa ExoS and ExoT","volume":"152","author":"Barbieri","year":"2004","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0016","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1128\/JB.185.24.7068-7076.2003","article-title":"FimX, a multidomain protein connecting environmental signals to twitching motility in Pseudomonas aeruginosa","volume":"185","author":"Huang","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0017","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1021\/bi100378m","article-title":"Probing the \"charge cluster mechanism\" in amphipathic helical cationic antimicrobial peptides","volume":"49","author":"Epand","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0018","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1038\/nmicrobiol.2016.162","article-title":"Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers","volume":"1","author":"Lam","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.colsurfb.2014.05.004","article-title":"Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2","volume":"120","author":"Ryder","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ijantimicag.2018.04.019_bib0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkm253","article-title":"De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia","volume":"60","author":"Deslouches","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:11:28Z","timestamp":1571332288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918301286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0924857918301286"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.04.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}